Loading viewer...
investor_presentation
Format: PDF investor_presentation
Axim Biotechnologies is developing innovative point-of-care diagnostic solutions focused on COVID-19 neutralizing antibody testing, cancer biomarker detection, and ocular disorder diagnostics. The company is pioneering the first rapid diagnostic test measuring functional neutralizing antibodies and partnering with institutions like Mayo Clinic and Arizona State University to advance its diagnostic portfolio.
investor_presentation
32 Pages
Maia Biotechnology